Skip to main content

Advertisement

Log in

Genetic and clinical heterogeneity of permanent neonatal diabetes mellitus: a single tertiary centre experience

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

Aims

Neonatal diabetes mellitus (NDM) is a rare disease where diabetes presents during the first six months of life. There are two types of this disorder: permanent neonatal diabetes (PNDM) and transient neonatal diabetes mellitus (TNDM). PNDM occurs due to mutations in genes involved in either beta-cell survival, insulin regulation, and secretion. This study aims to define the genetic aetiology and clinical phenotypes of PNDM in a large Egyptian cohort from a single centre.

Methods

Patients with PNDM who were diagnosed, treated, or referred for follow-up between January 2002 and January 2021 were identified and clinically phenotyped. All patients were tested for mutations in EIF2AK3, KCNJ11, ABCC8, INS, FOXP3, GATA4, GATA6, GCK, GLIS3, HNF1B, IER3IP1, PDX1, PTF1A, NEUROD1, NEUROG3, NKX2-2, RFX6, SLC2A2, SLC19A2, STAT3, WFS1, ZFP57 using targeted next-generation sequencing (NGS) panel. INSR gene mutation was tested in one patient who showed clinical features of insulin resistance.

Results

Twenty-nine patients from twenty-six families were diagnosed with PNDM. Pathogenic variants were identified in 17/29 patients (59%). EIF2AK3, INS, and KATP channel mutations were the commonest causes with frequency of 17%, 17%, and 14%, respectively. Patients with ABBC8 and KCNJ11 mutations were successfully shifted to sulfonylureas (SU). Paired data of glycosylated haemoglobin before and after SU transfer showed improved glycaemic control; 9.6% versus 7.1%, P = 0.041.

Conclusions

PNDM is a heterogenous disease with variable genotypes and clinical phenotypes among Egyptian patients. EIF2AK3, INS, ABCC8, and KCNJ11 mutations were the commonest causes of PNDM in the study cohort. All patients with KATP channel mutations were effectively treated with glyburide, reflecting the fact that genetic testing for patients with NDM is not only important for diagnosis but also for treatment plan and prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

All patients’ data are available in Table 2. Any additional materials are available from the corresponding author on reasonable request.

Code availability

The clinical data were analysed using the Statistical Package of Social Science (SPSS) programme for Windows (Standard version 21).

References

  1. Rabbone I, Barbetti F, Gentilella R et al (2017) Insulin therapy in neonatal diabetes mellitus: a review of the literature. Diabetes Res Clin Pract 129:126–135

    Article  CAS  Google Scholar 

  2. Hattersley AT, Greeley S, Polak M et al (2018) ISPAD clinical practice consensus guidelines 2018: the diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes 19(Suppl 27):47–63

    Article  Google Scholar 

  3. Beltrand J, Busiah K, Vaivre-Douret L et al (2020) Neonatal diabetes mellitus. Front Paediatr 8:540718

    Article  Google Scholar 

  4. Busiah, K., Drunat, S., Vaivre-Douret, L., et al. French NDM study group (2013). Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected]. The lancet. Diabetes & endocrinology, 1(3), 199–207

  5. Bowman, P., Mathews, F., Barbetti, F., et al. & Neonatal Diabetes International Collaborative Group (2021). Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients With Sulfonylurea-Treated ABCC8 Permanent Neonatal Diabetes. Diabetes care, 44(1), 35–42

  6. Cao B, Gong C, Wu D et al (2016) Genetic analysis and follow-up of 25 neonatal diabetes mellitus patients in China. J Diabetes Res 2016:6314368

    Article  CAS  Google Scholar 

  7. Russo, L., Iafusco, D., Brescianini, S., et al. & ISPED Early Diabetes Study Group (2011). Permanent diabetes during the first year of life: multiple gene screening in 54 patients. Diabetologia, 54(7), 1693–1701

  8. Demirbilek H, Arya VB, Ozbek MN et al (2015) Clinical characteristics and molecular genetic analysis of 22 patients with neonatal diabetes from the South-Eastern region of Turkey: predominance of non-KATP channel mutations. Eur J Endocrinol 172(6):697–705

    Article  CAS  Google Scholar 

  9. De Franco E, Flanagan SE, Houghton JA et al (2015) The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. Lancet (London, England) 386(9997):957–963

    Article  Google Scholar 

  10. Ellard S, Lango Allen H, De Franco E et al (2013) Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. Diabetologia 56(9):1958–1963

    Article  CAS  Google Scholar 

  11. Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med: Off J Am Coll Med Genet 17(5):405–424

    Article  Google Scholar 

  12. Habeb AM, Al-Magamsi MS, Eid IM et al (2012) Incidence, genetics, and clinical phenotype of permanent neonatal diabetes mellitus in northwest Saudi Arabia. Pediatr Diabetes 13(6):499–505

    Article  CAS  Google Scholar 

  13. Al-Khawaga S, Mohammed I, Saraswathi S et al (2019) The clinical and genetic characteristics of permanent neonatal diabetes (PNDM) in the state of Qatar. Mol Genet Genomic Med 7(10):e00753

    Article  Google Scholar 

  14. Suzuki S, Makita Y, Mukai T, Matsuo K, Ueda O, Fujieda K (2007) Molecular basis of neonatal diabetes in Japanese patients. J Clin Endocrinol Metab 92(10):3979–3985

    Article  CAS  Google Scholar 

  15. Al Senani A, Hamza N, Al Azkawi H et al (2018) Genetic mutations associated with neonatal diabetes mellitus in OMANI patients. J Pediatric Endocrinol Metab: JPEM 31(2):195–204

    Article  CAS  Google Scholar 

  16. Deeb A, Habeb A, Kaplan W et al (2016) Genetic characteristics, clinical spectrum, and incidence of neonatal diabetes in the emirate of AbuDhabi, United Arab Emirates. Am J Med Genet A 170(3):602–609

    Article  CAS  Google Scholar 

  17. Rubio-Cabezas, O., Patch, A. M., Minton, J. A., et al. Neonatal Diabetes International Collaborative Group, Hattersley, A. T., & Ellard, S. (2009). Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families. The Journal of clinical endocrinology and metabolism, 94(11), 4162–4170

  18. Garin I, Edghill EL, Akerman I et al (2010) Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis. Proc Natl Acad Sci United States of America 107(7):3105–3110

    Article  Google Scholar 

  19. Grulich-Henn J, Wagner V, Thon A et al (2010) Entities and frequency of neonatal diabetes: data from the diabetes documentation and quality management system (DPV). Diabetic Med: A J Br Diabetic Assoc 27(6):709–712

    Article  CAS  Google Scholar 

  20. Støy, J., Greeley, S. A., Paz, V. P., et al. & United States Neonatal Diabetes Working Group (2008). Diagnosis and treatment of neonatal diabetes: a United States experience. Pediatric diabetes, 9(5), 450–459

  21. Denkboy Öngen Y, Eren E, Demirbaş Ö et al (2021) Genotype and phenotype heterogeneity in neonatal diabetes: a single centre experience in Turkey. J Clin Res Pediatric Endocrinol 13(1):80–87

    Article  Google Scholar 

  22. Welters A, Meissner T, Konrad K et al (2020) Diabetes management in wolcott-rallison syndrome: analysis from the German/Austrian DPV database. Orphanet J Rare Dis 15(1):100

    Article  Google Scholar 

  23. Polak, M., Dechaume, A., Cavé, H., et al. & French ND (Neonatal Diabetes) Study Group (2008). Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group. Diabetes, 57(4), 1115–1119

  24. Rafiq, M., Flanagan, S. E., Patch, A. M., Shields, B. M., Ellard, S., Hattersley, A. T., & Neonatal Diabetes International Collaborative Group (2008). Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes care, 31(2), 204–209

  25. Osbak KK, Colclough K, Saint-Martin C et al (2009) Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat 30(11):1512–1526

    Article  CAS  Google Scholar 

  26. Njølstad PR, Søvik O, Cuesta-Muñoz A et al (2001) Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 344(21):1588–1592

    Article  Google Scholar 

  27. Ganie MA, Ali I, Ahangar AG et al (2012) Thiamine responsive megaloblastic anemia syndrome associated with patent ductus arteriosus: first case report from Kashmir Valley of the Indian subcontinent. Indian J Endocrinol Metab 16(4):646–650

    Article  CAS  Google Scholar 

  28. Huggard, D., Stack, T., Satas, S., & Gorman, C. O. (2015). Donohue syndrome and use of continuous subcutaneous insulin pump therapy. BMJ case reports, 2015, bcr2015210019

  29. Bacchetta R, Barzaghi F, Roncarolo MG (2018) From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation. Ann N Y Acad Sci 1417(1):5–22

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to all the families that participated in this study. Genetic testing performed at the University of Exeter Medical School was funded through a Wellcome Trust Senior Investigator Award (098395/Z/12/Z).

Funding

Genetic testing performed at the University of Exeter Medical School was funded through a Wellcome Trust Senior Investigator Award (098395/Z/12/Z). EDF is a Diabetes UK RD Lawrence fellow. SEF has a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (105636/Z/14/Z).

Author information

Authors and Affiliations

Authors

Contributions

W.L. initiated the main study idea. W.L., M.E., A.E., A.E., N.S., H.A., and M.A. contributed to the study design. W.L. collected patients’ samples, collected, and analysed the data. S.E.F. and E.D.F. analysed the genetic data. W.L. wrote the first draft of the manuscript. M.E., A.E., A.E., N.S., H.A., S.E.F., E.D.F., and M.A. revised and edited the manuscript. All the authors approved the final submitted manuscript.

Corresponding author

Correspondence to Wafaa Laimon.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This report has been approved by institutional review board and was in accordance with the 1964 Helsinki declaration and its later amendments.

Consent to participate

Informed written consents to publish the cases have been obtained from the patients’ parents.

Consent for publication

Patients signed informed consent regarding publishing their data. Parents of patient 14.1 signed informed consent for publication of Supplementary Fig. 1 and Supplementary Fig. 2.

Additional information

Managed by Massimo Porta.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 24 KB)

It shows acanthosis nigricans at neck, axilla and groin, prominent nipple, hypertrichosis and clitromegaly

Supplementary file2 (TIF 31212 KB)

592_2021_1788_MOESM3_ESM.tif

A: It shows prominent infraorbital creases, low set ears, thick lips, and acanthosis nigricans. B: It shows umbilical hernia and abdominal distension

Supplementary file3 (TIF 17586 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Laimon, W., El-Ziny, M., El-Hawary, A. et al. Genetic and clinical heterogeneity of permanent neonatal diabetes mellitus: a single tertiary centre experience. Acta Diabetol 58, 1689–1700 (2021). https://doi.org/10.1007/s00592-021-01788-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-021-01788-6

Keywords

Navigation